BRIEF-Spectrum Pharmaceuticals reports Q3 non-GAAP loss per share of $0.11
November 02, 2017 at 16:17 PM EDT
* Spectrum Pharmaceuticals reports third quarter 2017 financial results and pipeline update
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.